Hyunmo Yang

Hyunmo Yang is a highly experienced professional in the field of medicinal chemistry, currently serving as the Head of Medicinal Chemistry and Principal Research Scientist at Chong Kun Dang Pharm. since February 2006. Prior to this role, Hyunmo Yang worked as a researcher at Chungnam National University's Pharmaceutical Chemistry Research Institute, focusing on drug development for asthma treatment through Interleukin-5 inhibitors from March 2005 to February 2006. Hyunmo Yang's educational background includes a Doctorate in Medicinal Chemistry from Sungkyunkwan University, expected to be completed in February 2024, along with a Master's degree in Medicinal Chemistry and a Bachelor's degree in Chemistry, both from Chungnam National University.